Legislation | Enron-related regulatory issues hit derivatives industry

peterdefazio-jpg
Many US politicians are looking to use the Enron scandal to score political points or push pet issues through Congress (see box). Some of these initiatives seek to increase government oversight of the listed and over-the-counter derivatives markets. But the legislative calendar is crammed with higher priority issues such as the budget, appropriations bills and campaign finance reform, so the Enron-related measures face an uncertain future.

The Enron issues with the strongest chances of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: